CHARLES S HENRY
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology HOUSTON, TX NPI 1245201995
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology TX ANI Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$6,180.61
- Category: General Payments
- Program years: PY2018–2024
- Record count: 278
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,279.32 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,254.71 | 41 |
| Education | $24.61 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ANI Pharmaceuticals, Inc. | $366.29 | 2 |
| Otsuka America Pharmaceutical, Inc. | $108.52 | 4 |
| Amgen Inc. | $104.04 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $89.18 | 3 |
| Novo Nordisk AS | $82.62 | 4 |
| Acerta Pharma LLC | $72.90 | 3 |
| OPKO Pharmaceuticals, LLC | $71.72 | 4 |
| CorMedix Inc. | $60.91 | 2 |
| Retrophin, Inc. | $60.77 | 3 |
| AKEBIA THERAPEUTICS INC | $48.73 | 2 |
| Aurinia Pharma U.S., Inc. | $41.20 | 2 |
| Fresenius USA Marketing, Inc. | $40.23 | 2 |
| Mallinckrodt Hospital Products Inc. | $36.08 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.93 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $21.53 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.48 | 1 |
| Lilly USA, LLC | $19.19 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.